Clinical Applications of Enzymes - PowerPoint PPT Presentation

About This Presentation
Title:

Clinical Applications of Enzymes

Description:

Clinical Applications of Enzymes Clinical examples and case studies. – PowerPoint PPT presentation

Number of Views:124
Avg rating:3.0/5.0
Slides: 9
Provided by: ion46
Category:

less

Transcript and Presenter's Notes

Title: Clinical Applications of Enzymes


1
Clinical Applications of Enzymes
  • Clinical examples and case studies.

2
Hepatitis
  • A 36-year old man was admitted to a hospital
    following episodes of nausea, vomiting, and
    general malaise.
  • His urine was darker than usual.
  • Upon examination it was discovered that his liver
    was enlarged and tender to palpation.
  • Liver function tests were abnormal plasma ALT
    was 1500 IU/L (Alanine aminotransferase 6.0 21
    U/L) AST was 400 IU/L (Aspartate
    aminotransferase 7.0 20 U/L).
  • During the next 24 hours the man developed
    jaundice, and his plasma total bilirubin was 9.0
    mg/dL (0.2 1 mg/dL).
  • A diagnosis of hepatitis was made.

3
Biochemical Questions
  1. What reactions are catalyzed by AST and ALT? What
    is the coenzyme?
  2. What conditions are important to maintain in
    performing the enzyme assays?
  3. Which other enzymes might have been elevated in
    the plasma?
  4. How does total bilirubin relate to direct and
    indirect bilirubin?

4
Case discussion Hepatitis is an inflammation of
the liver.
  • Transaminases (amino acids metabolism)
  • Catalyze the transfer of a-amino groups from
    amino acid to a a-keto acid through the
    intermediary coenzyme pyridoxal phosphate
    (derived from the B6 vitamin, pyridoxine)
  • Amino acids enter into the Krebs cycle for
    oxidation to CO2 and H2O
  • Amino acid1 keto acid2 ? amino acid 2 keto
    acid1
  • (pyridoxal phosphate ? pyridoxamine phosphate)
    slide 11
  • ALT and AST

5
2. Temperature and pH
  • Excessive shaking and elevated temp should be
    avoided
  • Anticoagulants shouldn't inhibit the assays
  • Hemolysis should be avoided in order not to
    release enzymes of the blood cells

6
3. Other enzymes that could be elevated
  1. A number of proteins may leak from cell into
    plasma, such as other transaminases and LD can be
    elevated in liver diseases
  2. AST and ALT high levels occurs before jaundice is
    noted
  3. There is poor correlation of enzyme activity with
    severity of the disease

7
4. Bilirubin
  1. Biliribin is derived from the breaking down of
    the hemoglobin of aging red blood cells
  2. Bilirubin is insoluble in water to be excreted
    it is converted to a water-soluble bilirubin
    diglucuronide in the liver
  3. The first formed indirect bilirubin is bound to
    albumin and rapidly transported in plasma to the
    liver albumin is not taken into the liver cells
  4. Direct bilirubin (water soluble) is secreted
    into the bile canaliculus, together with other
    bile constituents and is collected in the
    gallbladder
  5. Some of the bile pigments are excreted in the
    feces and some water soluble bilirubin (not free
    bilirubin) is excreted by the kidney into the
    urine

8
Bilirubin continue
  • In hepatitis, the formation of water soluble
    bilirubin is less efficient
  • The secretion of direct bilirubin (water
    soluble bilirubin) into the bile canaliculi is
    impaired
  • The result is a backing-up of the bilirubin
    excretion with a build-up of total bilirubin in
    the blood.
  • The initial increase is expressed as a darkened
    urine, followed by jaundice
Write a Comment
User Comments (0)
About PowerShow.com